|
|
Volumn 11, Issue 2, 2001, Pages 116-120
|
|
St John's wort: A hidden risk for transplant patients
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTIARRHYTHMIC AGENT;
ANTICOAGULANT AGENT;
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
BARBITURIC ACID;
BENZODIAZEPINE;
CIPROFLOXACIN;
CYCLOSPORIN;
CYTOCHROME P450 3A4;
DIGOXIN;
DIURETIC AGENT;
FELODIPINE;
GLYCOPROTEIN P;
HYPERICUM PERFORATUM EXTRACT;
IMMUNOSUPPRESSIVE AGENT;
INDINAVIR;
ITRACONAZOLE;
LYMPHOCYTE ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
ORAL ANTIDIABETIC AGENT;
PLANT EXTRACT;
PREDNISOLONE;
PREDNISONE;
PRIMROSE OIL;
SEROTONIN UPTAKE INHIBITOR;
THEOPHYLLINE;
UNINDEXED DRUG;
WARFARIN;
ADULT;
ARTICLE;
BLEEDING;
CASE REPORT;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG INDUCED DISEASE;
DRUG METABOLISM;
FEMALE;
GINSENG;
GRAFT REJECTION;
HERBAL MEDICINE;
HUMAN;
HYPOGLYCEMIA;
HYPOKALEMIA;
HYPOTENSION;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
ORGAN TRANSPLANTATION;
PANCREAS TRANSPLANTATION;
RISK FACTOR;
SEDATION;
TREATMENT FAILURE;
|
|
EID: 0034990957
PISSN: 15269248
EISSN: None
Source Type: Journal
DOI: 10.7182/prtr.11.2.k761052k1r8364h5 Document Type: Article |
|
Times cited : (46)
|
|
References (15)
|
